Massimo Berger Selected Research

Hematologic Neoplasms (Hematological Malignancy)

3/2021	Post-Transplant Cyclophosphamide and Tacrolimus-Mycophenolate Mofetil Combination Governs GVHD and Immunosuppression Need, Reducing Late Toxicities in Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from HLA-Matched Donors.
3/2017	Post-Transplant Cyclophosphamide and Tacrolimus-Mycophenolate Mofetil Combination Prevents Graft-versus-Host Disease in Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from HLA-Matched Donors.
5/2016	Feasibility and Outcome of Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant High-Dose Cyclophosphamide for Children and Adolescents with Hematologic Malignancies: An AIEOP-GITMO Retrospective Multicenter Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Massimo Berger Research Topics

Disease

9	Graft vs Host Disease (Graft-Versus-Host Disease) 03/2021 - 10/2007
6	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2019 - 01/2011
5	Leukemia 11/2019 - 04/2012
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2018 - 02/2004
3	Hematologic Neoplasms (Hematological Malignancy) 03/2021 - 05/2016
3	Osteosarcoma (Osteogenic Sarcoma) 05/2008 - 05/2003
2	Lymphoma (Lymphomas) 02/2019 - 03/2015
2	Infections 01/2019 - 12/2017
2	Body Weight (Weight, Body) 03/2018 - 07/2012
2	Bronchiolitis Obliterans Syndrome 01/2018 - 02/2004
2	Neoplasms (Cancer) 03/2017 - 05/2008
1	COVID-19 01/2021
1	Aspergillosis 01/2021
1	Mucormycosis 02/2019
1	Stomatitis 01/2018
1	Pain (Aches) 01/2018
1	Bacterial Infections (Bacterial Infection) 01/2017
1	Febrile Neutropenia 01/2017
1	Osteopetrosis 01/2017
1	Fever (Fevers) 01/2017
1	Diabetes Insipidus 07/2012
1	Hypothyroidism 07/2012
1	Cardiotoxicity 04/2012
1	Lymphadenopathy 01/2011
1	Bacteremia 12/2010
1	Pneumonia (Pneumonitis) 05/2004
1	Brain Neoplasms (Brain Tumor) 05/2004
1	Mucositis 05/2004
1	Neoplasm Metastasis (Metastasis) 05/2003

Drug/Important Bio-Agent (IBA)

3	SteroidsIBA 11/2020 - 10/2007
2	HLA Antigens (Human Leukocyte Antigens)IBA 03/2021 - 08/2008
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2017 - 05/2016
2	Cytarabine (Cytosar-U)FDA LinkGeneric 03/2015 - 04/2012
2	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2012 - 01/2006
1	Antineoplastic Agents (Antineoplastics)IBA 03/2021
1	blinatumomabIBA 11/2019
1	Cidofovir (Vistide)FDA Link 01/2019
1	Probenecid (Benemid)FDA LinkGeneric 01/2019
1	posaconazole FDA Link 03/2018
1	SolutionsIBA 03/2018
1	salicylhydroxamic acid (SHAM)IBA 01/2018
1	Analgesics (Analgesic Drugs)IBA 01/2018
1	phytobacteriomycin (PBM)IBA 01/2018
1	Methylprednisolone FDA LinkGeneric 12/2017
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 03/2017
1	Tacrolimus (Prograf)FDA LinkGeneric 03/2017
1	ProcalcitoninIBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	Growth Hormone (Somatotropin)IBA 07/2012
1	fludarabineIBA 04/2012
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 04/2012
1	liposomal doxorubicin (Doxil)FDA Link 04/2012
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2011
1	CytokinesIBA 05/2008
1	HLA-DR Antigens (HLA-DR)IBA 05/2008
1	Methotrexate (Mexate)FDA LinkGeneric 01/2006
1	AnthracyclinesIBA 10/2005
1	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 05/2004
1	Etoposide (VP 16)FDA LinkGeneric 05/2004

Therapy/Procedure

7	Hematopoietic Stem Cell Transplantation 11/2019 - 08/2008
6	Therapeutics 03/2017 - 08/2008
5	Stem Cell Transplantation 02/2019 - 05/2003
5	Transplantation 01/2018 - 02/2004
4	Drug Therapy (Chemotherapy) 02/2019 - 05/2004
2	Cell Transplantation 01/2021 - 03/2017
2	Photopheresis 04/2015 - 10/2007
1	Low-Level Light Therapy (LLLT) 01/2018
1	Lasers (Laser) 01/2018
1	Laser Therapy (Surgery, Laser) 01/2018
1	Donor Selection 08/2008
1	Immunotherapy 05/2008
1	Induction Chemotherapy 10/2005